loader image
Thursday, December 7, 2023
68 F
McAllen
We Welcome your Press Release
- Advertisement -

American Medical Association statement on antibody treatments

Translate to Spanish or other 102 languages!

We are pleased that the FDA is following the scientific evidence and limiting the use of monoclonal antibody treatments to those that are effective against the Omicron variant. Image for illustration purposes.
We are pleased that the FDA is following the scientific evidence and limiting the use of monoclonal antibody treatments to those that are effective against the Omicron variant. Image for illustration purposes.

Mega Doctor News

- Advertisement -

Gerald E. Harmon, M.D.
President, American Medical Association

“Given the latest data showing the Omicron variant of SARS-CoV-2 is responsible for 99% of current COVID-19 infections, we are pleased that the FDA is following the scientific evidence and limiting the use of monoclonal antibody treatments to those that are effective against the Omicron variant. Limiting the use of these treatments will help ensure patients receive the best available therapy. We encourage physicians to reference the current National Institutes of Health (NIH) COVID-19 treatment guidelines for the latest information on authorized therapies and recommendations for their use.

“We continue to strongly urge every eligible individual to make sure they are up to date on their COVID-19 vaccinations, including booster doses. The Omicron variant is highly contagious and the unvaccinated remain most at risk of severe illness, hospitalization and death if infected. Data further suggests that a booster dose provides greater protection against the Omicron variant.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Use Of Anticoagulant Drug After Aortic Valve Replacement Lowers Mortality Risk

The use of bioprosthetic aortic valve replacement has increased significantly during the past decade.

Salood Joins Driscoll to Deliver Non-Medical Financial Aid to Child Cancer Patients

The aid will go to indirect healthcare expenses including mortgage, utilities, lodging, food, and more

Medicare is Overpaying for Generic Drugs

The researchers found evidence that the private insurers that sponsor Medicare Part D are artificially inflating the costs of certain generic drugs by overpaying pharmacies.
- Advertisement -
×